In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
National Institutes of Health (NIH)
Maximum funding amount: $500,000 per year
Maximum project duration: 5 years
Support the development of in vivo high-resolution imaging technologies for the human inner ear.
Focus on improving resolution of current imaging techniques or developing new techniques.
Individuals with deafness or communication disorders.
Researchers and institutions involved in auditory and vestibular research.
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local and state governments, and tribal governments.
Non-domestic entities (foreign organizations) are also eligible.
Open to U.S. and non-domestic entities.
Foreign components of U.S. organizations are allowed.
Projects must focus on developing or improving imaging technologies for the inner ear.
Must articulate a clear path for application in awake humans or define limitations for anesthetized humans.
Maximum funding per grant is less than $500,000 direct costs per year.
No cost-sharing is required.
Application due date: October 1, 2026.
Earliest submission date: May 3, 2025.
Applicant organizations may submit more than one application, provided each is scientifically distinct.
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated based on scientific and technical merit.
Applications will undergo peer review and selection based on established NIH policies.
Scientific merit, relevance to program priorities, and availability of funds will be considered.
Encourages a multidisciplinary team approach.
High-risk clinical trials must apply to a companion funding opportunity.
Projects should align with NIDCD's mission to improve human health through auditory and vestibular research.
Strong emphasis on non-invasive techniques may provide a competitive edge.
Demonstrating clear clinical applicability and innovative imaging techniques.
Submitting overlapping applications or failing to meet submission guidelines.
Engage with NIH staff early in the process, especially for clinical trials.
Highlight the potential for significant advancements in diagnosing and treating inner ear disorders.